Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT07112066
Eligibility Criteria:
Inclusion Criteria:
* Participants with cardiac ATTR amyloidosis, as recently defined by multi-societal criteria, who are about to start tafamidis at the University Hospital Zurich
Exclusion Criteria:
* Any other disease-modifying therapy (e.g. patisiran)
* Ongoing supraventricular arrhythmia
* Ventricular pacing
* Prior septal myocardial infarction
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07112066
Study Brief:
Protocol Section:
NCT07112066